Linezolid
NDC 63323-713, Linezolid, injection, solution, from Fresenius Kabi USA, LLC.
- Product NDC
- 63323-713
- Status
- Listed
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204764
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63323-713 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LINEZOLID2 mg/mL
Pharmacologic classes
Oxazolidinone Antibacterial [EPC]; Oxazolidinones [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63323-713-13 | 63323071313 | 10 BAG in 1 CASE (63323-713-13) / 300 mL in 1 BAG (63323-713-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/cc3e3ea4-50aa-49ee-a8bc-fb48bfc8e014Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=63323-713
Use it
Look up 63323-713 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63323-713 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63323-713. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.